Ahmad R, Rah B, Bastola D, Dhawan P, Singh AB (2017) Obesity-induces organ and tissue specific tight junction restructuring and barrier deregulation by claudin switching. Sci Rep 7(1):1–16
Al-Sadi R, Boivin M, Ma T (2009) Mechanism of cytokine modulation of epithelial tight junction barrier. Front Biosci (Landmark Ed) 14:2765–2778. https://doi.org/10.2741/3413
Baranova IN, Souza AC, Bocharov AV, Vishnyakova TG, Hu X, Vaisman BL, Amar MJ, Chen Z, Kost Y, Remaley AT, Patterson AP, Yuen PS, Star RA, Eggerman TL (2016) Human SR-BI and SR-BII potentiate lipopolysaccharide-induced inflammation and acute liver and kidney injury in mice. J Immunol 196(7):3135–3147. https://doi.org/10.4049/jimmunol.1501709
Belizario JE, Faintuch J (2018) Microbiome and gut dysbiosis. Exp Suppl 109:459–476. https://doi.org/10.1007/978-3-319-74932-7_13
Bhathena J, Martoni C, Kulamarva A, Urbanska AM, Malhotra M, Prakash S (2009) Orally delivered microencapsulated live probiotic formulation lowers serum lipids in hypercholesterolemic hamsters. J Med Food 12(2):310–319. https://doi.org/10.1089/jmf.2008.0166
Blumfield M, Abbott K, Duve E, Cassettari T, Marshall S, Fayet-Moore F (2020) Examining the health effects and bioactive components in Agaricus bisporus mushrooms: A scoping review. J Nutr Biochem 84:108453
Borody TJ, Paramsothy S, Agrawal G (2013) Fecal microbiota transplantation: indications, methods, evidence, and future directions. Curr Gastroenterol Rep 15(8):337. https://doi.org/10.1007/s11894-013-0337-1
Bray GA, Fruhbeck G, Ryan DH, Wilding JP (2016) Management of obesity. Lancet 387(10031):1947–1956. https://doi.org/10.1016/S0140-6736(16)00271-3
Brun P, Castagliuolo I, Di Leo V, Buda A, Pinzani M, Palu G, Martines D (2007) Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol 292(2):G518–525. https://doi.org/10.1152/ajpgi.00024.2006
Cancello R, Tordjman J, Poitou C, Guilhem G, Bouillot JL, Hugol D, Coussieu C, Basdevant A, Hen B, Bedossa A, Guerre-Millo P, Clement K (2006) Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity. Diabetes 55(6):1554–1561. https://doi.org/10.2337/db06-0133
Cani PD, Delzenne NM (2007) Gut microflora as a target for energy and metabolic homeostasis. Curr Opin Clin Nutr Metab Care 10(6):729–734. https://doi.org/10.1097/MCO.0b013e3282efdebb
Cani PD, Neyrinck AM, Fava F, Knauf C, Burcelin RG, Tuohy KM, Gibson GR, Delzenne NM (2007) Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 50(11):2374–2383. https://doi.org/10.1007/s00125-007-0791-0
Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM, Burcelin R (2008) Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57(6):1470–1481. https://doi.org/10.2337/db07-1403
Cani PD, Possemiers S, Van de Wiele T, Guiot Y, Everard A, Rottier O, Geurts L, Naslain D, Neyrinck A, Lambert DM, Muccioli GG, Delzenne NM (2009) Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58(8):1091–1103. https://doi.org/10.1136/gut.2008.165886
Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, Fierer N, Pena AG, Goodrich JK, Gordon JI, Huttley GA, Kelley ST, Knights D, Koenig JE, Ley RE, Lozupone CA, McDonald D, Muegge BD, Pirrung M, Reeder J, Sevinsky JR, Turnbaugh PJ, Walters WA, Widmann J, Yatsunenko T, Zaneveld J, Knight R (2010) QIIME allows analysis of high-throughput community sequencing data. Nat Methods 7(5):335–336. https://doi.org/10.1038/nmeth.f.303
Chang CJ, Lin CS, Lu CC, Martel J, Ko YF, Ojcius DM, Tseng SF, Wu TR, Chen YY, Young JD, Lai HC (2015) Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota. Nat Commun 6:7489. https://doi.org/10.1038/ncomms8489
Chang CJ, Lu CC, Lin CS, Martel J, Ko YF, Ojcius DM, Wu TR, Tsai YH, Yeh TS, Lu JJ, Lai HC, Young JD (2018) Antrodia cinnamomea reduces obesity and modulates the gut microbiota in high-fat diet-fed mice. Int J Obes (Lond) 42(2):231–243. https://doi.org/10.1038/ijo.2017.149
Chen D, Iijima H, Nagaishi T, Nakajima A, Russell S, Raychowdhury R, Morales V, Rudd CE, Utku N, Blumberg RS (2004) Carcinoembryonic antigen-related cellular adhesion molecule 1 isoforms alternatively inhibit and costimulate human T cell function. J Immunol 172(6):3535–3543. https://doi.org/10.4049/jimmunol.172.6.3535
Chooi YC, Ding C, Magkos F (2019) The epidemiology of obesity. Metabolism 92:6–10
Christensen R, Kristensen PK, Bartels EM, Bliddal H, Astrup A (2007) Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials. Lancet 370(9600):1706–1713. https://doi.org/10.1016/S0140-6736(07)61721-8
Cui HL, Chen Y, Wang SS, Kai GQ, Fang YM (2011) Isolation, partial characterisation and immunomodulatory activities of polysaccharide from Morchella esculenta. J Sci Food Agric 91(12):2180–2185. https://doi.org/10.1002/jsfa.4436
Daniel H, Gholami AM, Berry D, Desmarchelier C, Hahne H, Loh G, Mondot S, Lepage P, Rothballer M, Walker A, Bohm C, Wenning M, Wagner M, Blaut M, Schmitt-Kopplin P, Kuster B, Haller D, Clavel T (2014) High-fat diet alters gut microbiota physiology in mice. ISME J 8(2):295–308. https://doi.org/10.1038/ismej.2013.155
Delarue J, Magnan C (2007) Free fatty acids and insulin resistance. Curr Opin Clin Nutr Metab Care 10(2):142–148. https://doi.org/10.1097/MCO.0b013e328042ba90
Dethlefsen L, McFall-Ngai M, Relman DA (2007) An ecological and evolutionary perspective on human-microbe mutualism and disease. Nature 449(7164):811–818. https://doi.org/10.1038/nature06245
Ding S, Lund PK (2011) Role of intestinal inflammation as an early event in obesity and insulin resistance. Curr Opin Clin Nutr Metab Care 14(4):328–333. https://doi.org/10.1097/MCO.0b013e3283478727
Dokladny K, Zuhl MN, Moseley PL (2016) Intestinal epithelial barrier function and tight junction proteins with heat and exercise. J Appl Physiol (1985) 120(6):692–701. https://doi.org/10.1152/japplphysiol.00536.2015
Dubois M, Gilles KA, Hamilton JK, Rebers Pt, Smith F (1956) Colorimetric method for determination of sugars and related substances. Anal Chem 28(3):350–356
Etxeberria U, Fernandez-Quintela A, Milagro FI, Aguirre L, Martinez JA, Portillo MP (2013) Impact of polyphenols and polyphenol-rich dietary sources on gut microbiota composition. J Agric Food Chem 61(40):9517–9533. https://doi.org/10.1021/jf402506c
Ezzati M, Bentham J, Di Cesare M, Bilano V, Bixby H, Zhou B, Stevens GA, Riley LM, Taddei C, Hajifathalian K (2017) Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults. Lancet 390(10113)
Ferreira CFR, Vaz IA, Vasconcelos J, Martins A (2010) Compounds from wild mushrooms with antitumor potential. Anti-Cancer Agents Med Chem 10(5):424–436
Ghanim H, Abuaysheh S, Sia CL, Korzeniewski K, Chaudhuri A, Fernandez-Real JM, Dandona P (2009) Increase in plasma endotoxin concentrations and the expression of Toll-like receptors and suppressor of cytokine signaling-3 in mononuclear cells after a high-fat, high-carbohydrate meal: implications for insulin resistance. Diabetes Care 32(12):2281–2287. https://doi.org/10.2337/dc09-0979
Gibson GR, Probert HM, Loo JV, Rastall RA, Roberfroid MB (2004) Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutr Res Rev 17(2):259–275. https://doi.org/10.1079/NRR200479
Hao L, Sheng Z, Lu J, Tao R, Jia S (2016) Characterization and antioxidant activities of extracellular and intracellular polysaccharides from Fomitopsis pinicola. Carbohydr Polym 141:54–59. https://doi.org/10.1016/j.carbpol.2015.11.048
He X, Wei Z, Wang J, Kou J, Liu W, Fu Y, Yang Z (2016) Alpinetin attenuates inflammatory responses by suppressing TLR4 and NLRP3 signaling pathways in DSS-induced acute colitis. Sci Rep 6:28370. https://doi.org/10.1038/srep28370
Hotamisligil GS (2006) Inflammation and metabolic disorders. Nature 444(7121):860–867. https://doi.org/10.1038/nature05485
Hobbs C (1995) Kombucha: tea mushroom: the essential guide. Botanical Press
Hu M, Chen Y, Wang C, Cui H, Duan P, Zhai T, Yang Y, Li S (2013) Induction of apoptosis in HepG2 cells by polysaccharide MEP-II from the fermentation broth of Morchella esculenta. Biotechnol Lett 35(1):1–10. https://doi.org/10.1007/s10529-012-0917-4
Kang JG, Park C-Y (2012) Anti-obesity drugs: a review about their effects and safety. Diabetes Metab J 36(1):13
Kanwal S, Joseph TP, Owusu L, Xiaomeng R, Meiqi L, Yi X (2018) A polysaccharide isolated from Dictyophora indusiata promotes recovery from antibiotic-driven intestinal dysbiosis and improves gut epithelial barrier function in a mouse model. Nutrients. https://doi.org/10.3390/nu10081003
Kaur N, Chen CC, Luther J, Kao JY (2011) Intestinal dysbiosis in inflammatory bowel disease. Gut Microbes 2(4):211–216. https://doi.org/10.4161/gmic.2.4.17863
Kim K-A, Gu W, Lee I-A, Joh E-H, Kim D-H (2012) High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway. PLoS ONE 7(10): e47713
Kim J, Lee H, Lim J, Oh J, Shin SS, Yoon M (2017) The angiogenesis inhibitor ALS-L1023 from Lemon-Balm leaves attenuates high-fat diet-induced nonalcoholic fatty liver disease through regulating the visceral adipose-tissue function. Int J Mol Sci. https://doi.org/10.3390/ijms18040846
Kim MH, Park SJ, Kim JH, Seong JB, Kim KM, Woo HA, Lee DS (2018) Peroxiredoxin 5 regulates adipogenesis-attenuating oxidative stress in obese mouse models induced by a high-fat diet. Free Radic Biol Med 123:27–38. https://doi.org/10.1016/j.freeradbiomed.2018.05.061
Kozarski MS, Klaus AS, Vunduk J, Jakovljević DM, Jadranin MB, Nikšić MP (2020) Health impact of the commercially cultivated mushroom Agaricus bisporus and wild-growing mushroom Ganoderma resinaceum—a comparative overview. J Serb Chem Soc 85(6):721–735
Le Chatelier E, Nielsen T, Qin J, Prifti E, Hildebrand F, Falony G, Almeida M, Arumugam M, Batto JM, Kennedy S, Leonard P, Li J, Burgdorf K, Grarup N, Jorgensen T, Brandslund I, Nielsen HB, Juncker AS, Bertalan M, Levenez F, Pons N, Rasmussen S, Sunagawa S, Tap J, Tims S, Zoetendal EG, Brunak S, Clement K, Dore J, Kleerebezem M, Kristiansen K, Renault P, Sicheritz-Ponten T, de Vos WM, Zucker JD, Raes J, Hansen T, Meta, Bork P, Wang J, Ehrlich SD, Pedersen O (2013) Richness of human gut microbiome correlates with metabolic markers. Nature 500(7464):541–546 H. I. T. c. https://doi.org/10.1038/nature12506
Ley RE, Backhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI (2005) Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A 102(31):11070–11075. https://doi.org/10.1073/pnas.0504978102
Ley RE, Turnbaugh PJ, Klein S, Gordon JI (2006) Human gut microbes associated with obesity. Nature 444(7122):1022–1023
Liang Z, Yuan Z, Li G, Fu F, Shan Y (2018) Hypolipidemic, antioxidant, and antiapoptotic effects of polysaccharides extracted from reishi mushroom, Ganoderma lucidum (Leysser: Fr) Karst, in Mice Fed a High-Fat Diet. J Med Food 21(12):1218–1227. https://doi.org/10.1089/jmf.2018.4182
Liou AP, Paziuk M, Luevano JM Jr, Machineni S, Turnbaugh PJ, Kaplan LM (2013) Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity. Sci Transl Med 5(178):178ra141. https://doi.org/10.1126/scitranslmed.3005687
Liu C, Peng L, Qian M, Hao J (2016) Antihyperlipidemic effect of endo-polysaccharide of Morchella esculenta and chemical structure analysis. Oxid Commun 39:968–976
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25(4):402–408. https://doi.org/10.1006/meth.2001.1262
Lu Y, Zhao A, Wu Y, Zhao Y, Yang X (2019) Soybean soluble polysaccharides enhance bioavailability of genistein and its prevention against obesity and metabolic syndrome of mice with chronic high fat consumption. Food Funct 10(7):4153–4165. https://doi.org/10.1039/c8fo02379d
Maury E, Brichard SM (2010) Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrinol 314(1):1–16. https://doi.org/10.1016/j.mce.2009.07.031
Mingyi Y, Belwal T, Devkota HP, Li L, Luo Z (2019) Trends of utilizing mushroom polysaccharides (MPs) as potent nutraceutical components in food and medicine: a comprehensive review. Trends Food Sci Technol 92:94–110
Neyrinck AM, Possemiers S, Druart C, Van de Wiele T, De Backer F, Cani PD, Larondelle Y, Delzenne NM (2011) Prebiotic effects of wheat arabinoxylan related to the increase in bifidobacteria, Roseburia and Bacteroides/Prevotella in diet-induced obese mice. PLoS ONE 6(6):e20944. https://doi.org/10.1371/journal.pone.0020944
Parlee SD, Lentz SI, Mori H, MacDougald OA (2014) Quantifying size and number of adipocytes in adipose tissue. Methods Enzymol 537:93–122. https://doi.org/10.1016/B978-0-12-411619-1.00006-9
Qatanani M, Lazar MA (2007) Mechanisms of obesity-associated insulin resistance: many choices on the menu. Genes Dev 21(12):1443–1455. https://doi.org/10.1101/gad.1550907
Rathore H, Prasad S, Sharma S (2017) Mushroom nutraceuticals for improved nutrition and better human health: a review. PharmaNutrition 5(2):35–46
Ridaura VK, Faith JJ, Rey FE, Cheng J, Duncan AE, Kau AL, Griffin NW, Lombard V, Henrissat B, Bain JR, Muehlbauer MJ, Ilkayeva O, Semenkovich CF, Funai K, Hayashi DK, Lyle BJ, Martini MC, Ursell LK, Clemente JC, Van Treuren W, Walters WA, Knight R, Newgard CB, Heath AC, Gordon JI (2013) Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science 341(6150):1241214. https://doi.org/10.1126/science.1241214
Sánchez de Medina F, Romero-Calvo I, Mascaraque C, Martínez-Augustin O (2014) Intestinal inflammation and mucosal barrier function. Inflamm Bowel Dis 20(12):2394–2404
Schreiber S, Nikolaus S, Hampe J (1998) Activation of nuclear factor kappa B inflammatory bowel disease. Gut 42(4):477–484. https://doi.org/10.1136/gut.42.4.477
Segula D (2014) Complications of obesity in adults: a short review of the literature. Malawi Med J 26(1):20–24. https://www.ncbi.nlm.nih.gov/pubmed/24959321
Tang JL, Liu BY, Ma KW (2008) Traditional Chinese medicine. Lancet 372(9654):1938–1940. https://doi.org/10.1016/S0140-6736(08)61354-9
Tietel Z, Masaphy S (2018) True morels (Morchella)-nutritional and phytochemical composition, health benefits and flavor: a review. Crit Rev Food Sci Nutr 58(11):1888–1901. https://doi.org/10.1080/10408398.2017.1285269
Tilg H, Kaser A (2011) Gut microbiome, obesity, and metabolic dysfunction. J Clin Invest 121(6):2126–2132. https://doi.org/10.1172/JCI58109
Tilg H, Moschen AR (2014) Microbiota and diabetes: an evolving relationship. Gut 63(9):1513–1521. https://doi.org/10.1136/gutjnl-2014-306928
Tsukahara T, Koyama H, Okada M, Ushida K (2002) Stimulation of butyrate production by gluconic acid in batch culture of pig cecal digesta and identification of butyrate-producing bacteria. J Nutr 132(8):2229–2234. https://doi.org/10.1093/jn/132.8.2229
Tung Y-T, Pan C-H, Chien Y-W, Huang H-Y (2020) Edible mushrooms: novel medicinal agents to combat metabolic syndrome and associated diseases. Curr Pharm Design 26(39):4970–4981
Turnbaugh PJ, Backhed F, Fulton L, Gordon JI (2008) Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 3(4):213–223. https://doi.org/10.1016/j.chom.2008.02.015
Um MY, Moon MK, Ahn J, Ha Y, T (2013) Coumarin attenuates hepatic steatosis by down-regulating lipogenic gene expression in mice fed a high-fat diet. Br J Nutr 109(9):1590–1597. https://doi.org/10.1017/S0007114512005260
van Herpen NA, Schrauwen-Hinderling VB (2008) Lipid accumulation in non-adipose tissue and lipotoxicity. Physiol Behav 94(2):231–241. https://doi.org/10.1016/j.physbeh.2007.11.049
Wilson B, Whelan K (2017) Prebiotic inulin-type fructans and galacto-oligosaccharides: definition, specificity, function, and application in gastrointestinal disorders. J Gastroenterol Hepatol 32(Suppl 1):64–68. https://doi.org/10.1111/jgh.13700
Yoshimoto S, Loo TM, Atarashi K, Kanda H, Sato S, Oyadomari S, Iwakura Y, Oshima K, Morita H, Hattori M, Honda K, Ishikawa Y, Hara E, Ohtani N (2013) Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature 499(7456):97–101. https://doi.org/10.1038/nature12347
Zhang C, Zhang M, Wang S, Han R, Cao Y, Hua W, Mao Y, Zhang X, Pang X, Wei C, Zhao G, Chen Y, Zhao L (2010) Interactions between gut microbiota, host genetics and diet relevant to development of metabolic syndromes in mice. ISME J 4(2):232–241. https://doi.org/10.1038/ismej.2009.112
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Disclaimer:
This article is autogenerated using RSS feeds and has not been created or edited by OA JF.
Click here for Source link (https://www.springeropen.com/)
